Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Gains from Investment Securities (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Gains from Investment Securities for 17 consecutive years, with $17.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 140.48% year-over-year to $17.0 million, compared with a TTM value of $40.0 million through Sep 2025, up 193.02%, and an annual FY2024 reading of $6.0 million, up 175.0% over the prior year.
  • Gains from Investment Securities was $17.0 million for Q3 2025 at Dentsply Sirona, up from -$15.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $42.0 million in Q4 2024 and bottomed at -$44.0 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is -$263157.9, with a median of -$2.0 million recorded in 2022.
  • The sharpest move saw Gains from Investment Securities surged 1166.67% in 2021, then plummeted 2000.0% in 2024.
  • Year by year, Gains from Investment Securities stood at -$36.0 million in 2021, then skyrocketed by 202.78% to $37.0 million in 2022, then plummeted by 118.92% to -$7.0 million in 2023, then soared by 700.0% to $42.0 million in 2024, then plummeted by 59.52% to $17.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for XRAY at $17.0 million in Q3 2025, -$15.0 million in Q2 2025, and -$4.0 million in Q1 2025.